# ‘Too Good to Be True’: A Chinese Study on Timing Cancer Therapy Is Retracted

> **Open Intelligence Dossier** · First detected: 2026-06-26 03:07 UTC · Category: Health

## Executive Summary
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"‘Too Good to Be True’: A Chinese Study on Timing Cancer Therapy Is Retracted" is generating significant coverage in the Health category, with 1 articles from 1 distinct sources tracked by PULSE so far.


Outlets currently covering the story include 매일경제. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| 매일경제 | Four months after the announcement, a Chinese research team paper containing that the time zone for | [Source Link](https://news.google.com/rss/articles/CBMiUkFVX3lxTE5tLWhJS25QMHVBRzliaDBIQXhEQjFGNkNVNUFMUmVGS3dRNXBKQnlZZUROVHV6TkpoazZDdlFJTEZTN3BJc0ZUeWJPcEV5TU1nWFE?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-06-26/too-good-to-be-true-a-chinese-study-on-timing-cancer-therapy-is-retracted*